News

Prague-Weizmann Summer School on Drug Discovery 2019

31/07/2019
We are proud to announce that IOCB Tech is a co-organizer of the 6th year of the Prague-Weizmann Summer School on Drug Discovery 2019. Read more

SHINE and IOCB enter Lu-177 process license agreement

16/05/2019
SHINE Medical Technologies, Inc. and IOCB Prague have entered into an intellectual property license agreement providing SHINE with a global, exclusive license to a novel method for separating rare earth elements. Read more

Prague-Weizmann Winter School In Drug Discovery

28/05/2018
Following four successful years of the Prague Summer School on Advances in Drug Discovery, this year the school will be held jointly with the Weizmann Institute of Science in Rehovot, Israel. Read more

IOCB Tech at BioInternational in Boston

28/05/2018
IOCB Tech will be at the 25th anniversary of BioInternational in Boston. We are part of the BioMedChemCluster and can be found at Booth 1908a. Read more

IOCB Tech at BioVaria 2018

23/02/2018
IOCB Tech is again one of the partners at the BioVaria conference. The event will take place April 23-24, 2018, in Munich, Germany. Read more

Featured projects

11/01/2018
Three featured projects with self-explanatory videos. Please follow the link and like always if you would like to learn more about the projects and/or IOCB-TTO please don’t hesitate to contact us via email or phone. Read more

Successful Basel Life Science Week

11/08/2016
IOCB was successfully presenting four technologies at Basel Life Science Week September 19-22. Read more

New granted US patent

29/07/2016
Lukas Drasar and Miroslav Ledvina from IOCB Prague invented in collaboration with Zina Korvasova and Jaroslav Turanek from the Faculty of Veterinary Medicine of the University of Veterinary and Pharmaceutical Science Brno new lipopolyamines. Read more

Awarded US patent

01/06/2016
Congratulations to Filip Teply and Mirek Hajek, the patent application for their development of “Helquat derivates” was granted in The United States. For more information about the patent please follow it on Espacenet. Read more